Advertisement

Journal of Gastroenterology

, Volume 54, Issue 12, pp 1106–1112 | Cite as

Familial pancreatic cancer risk: a population-based study in Utah

  • Divyanshoo R. Kohli
  • Ken Robert Smith
  • Jathine Wong
  • Zhe Yu
  • Kenneth Boucher
  • Douglas O. Faigel
  • Rahul Pannala
  • Randall W. Burt
  • Karen Curtin
  • N. Jewel SamadderEmail author
Original Article—Liver, Pancreas, and Biliary Tract

Abstract

Introduction

Pancreas adenocarcinoma (PC) has an undefined hereditary component. We quantified the familial risk of PC among relatives of patients diagnosed with PC and stratified it based on anatomic location of PC and age and sex of the proband.

Methods

This is a retrospective, population-based, case–control study of PC diagnosed in Utah between 1980 and 2011. The Utah population database and cancer registry were used to identify index patients with PC. The risk of PC in first-degree relatives (FDRs), second-degree relatives (SDRs), and first cousins (FCs) of probands was compared with randomly selected sex- and age-matched population controls.

Results

A total of 4,095 patients and 40,933 controls were identified. The relative risk (RR) of PC was 1.76 (95% CI 1.35–2.29) in FDRs, 1.42 (95% CI 1.18–1.7) in SDRs and 1.08 (95% CI 0.95–1.23) in FCs of probands compared to relatives of PC-free controls. The RR were elevated in FDRs (1.96, 95% CI 1.45–2.65), SDRs (1.54, 95% CI 1.19–1.98) and FCs (1.18, 95% CI 1.0–1.64) of female probands. Among probands diagnosed as < 65 years, RR was 2.12 (95% CI 1.37–3.28) in FDRs, 1.94 (95% CI 1.44–2.62) in SDRs, and 1.28 (95% CI 1.0–1.64) in FCs. Overall, the RR for PC was elevated in FDRs regardless of the anatomic location of PC.

Discussion

There is an increased risk of PC in FDR and more distant relatives of patients with PC. Relatives of female patients with PC and patients diagnosed at age < 65 years are at a significantly increased risk of PC.

Keywords

Pancreatic cancer Familial Hereditary cancer 

Abbreviations

PC

Pancreas adenocarcinoma

UCR

Utah cancer registry

UPDB

Utah population database

FDR

First-degree relative (parent, child, sibling)

SDR

Second-degree relative (aunt/uncle, niece/nephew, grandparent/grandchild)

FC

First cousin

RR

Relative risk

Notes

Author contributions

Drs. Samadder and Curtin had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analyses. Study concept and design: RWB, KC, NJS; acquisition, analysis and interpretation of data: GM, KS, DK, KC, JW, RP, KB, LP, RWB, NJS; drafting of the manuscript: DK, KC, and NJS; critical revision of the manuscript for important intellectual content: DK, GM, KC, KS, HS, DA, DF, RP, RWB; statistical analysis: JW, KC, LP; obtained funding: NJS and RWB.

Funding

The study was funded by the National Cancer Institute, American College of Gastroenterology, American Society for Gastrointestinal Endoscopy and the Huntsman Cancer Foundation. The funding sources did not play a role in the design, conduct or reporting of the study or in the decision to submit the manuscript for publication. Support for this project was provided by NCI grants P01-CA073992 (RWB), R01-CA040641 (RWB), an Endoscopic Research Award from the American Society for Gastrointestinal Endoscopy (NJS) and a Junior Faculty Career Development Award from the American College of Gastroenterology (NJS). Partial support for the Utah Population Database and this project was provided by the Huntsman Cancer Institute Cancer Center Support Grant P30CA042014 from the National Cancer institute and the Huntsman Cancer Foundation. Support for the Utah Cancer Registry is provided by Contract #HHSN 261201000026C from the National Cancer Institute with additional support from the Utah Department of Health and the University of Utah.

Compliance with ethical standards

Conflict of interest

NJS is a consultant for Cook Medical, Cancer Prevention Pharmaceuticals and Janssen Research and Development. No other authors have a conflict of interest to disclose.

Supplementary material

535_2019_1597_MOESM1_ESM.docx (13 kb)
Supplementary file1 (DOCX 13 kb)

References

  1. 1.
    Chiaravalli M, Reni M, O’Reilly EM. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies. Cancer Treat Rev. 2017;60:32–433.CrossRefGoogle Scholar
  2. 2.
    Kohli DR, Kapoor A, BouHaidar D, et al. Requirement of a single high-risk feature as an indication for EUS for the diagnosis of asymptomatic pancreatic cysts. Pancreatology. 2016;16:1015–9.CrossRefGoogle Scholar
  3. 3.
    Canto MI, Harinck F, Hruban RH, et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62:339–47.CrossRefGoogle Scholar
  4. 4.
    Shirts BH, Burt RW, Mulvihill SJ, et al. A population-based description of familial clustering of pancreatic cancer. Clin Gastroenterol Hepatol. 2010;8:812–6.CrossRefGoogle Scholar
  5. 5.
    Samadder NJ, Smith KR, Wong J, et al. Familial risk of biliary tract cancers: a population-based study in Utah. Dig Dis Sci. 2016;61:3627–32.CrossRefGoogle Scholar
  6. 6.
    Samadder NJ, Curtin K, Wong J et al (2014) Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah. Clin Gastroenterol Hepatol 12:2078–2084.e1–2CrossRefGoogle Scholar
  7. 7.
    Jorde LB. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet. 1989;53(Pt 4):339–55.CrossRefGoogle Scholar
  8. 8.
    Samadder NJ, Smith KR, Hanson H, et al. Familial risk in patients with carcinoma of unknown primary. JAMA Oncol. 2016;2:340–6.CrossRefGoogle Scholar
  9. 9.
    Curtin K, Smith KR, Fraser A, et al. Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice. Int J Cancer. 2013;133:2444–533.CrossRefGoogle Scholar
  10. 10.
    Samadder NJ, Curtin K, Tuohy TMF, et al. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology. 2014;147:814–21.CrossRefGoogle Scholar
  11. 11.
    Schenk M, Schwartz AG, O’Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst. 2001;93:640–4.CrossRefGoogle Scholar
  12. 12.
    Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. 2001;7:738–44.PubMedGoogle Scholar
  13. 13.
    Becker AE, Hernandez YG, Frucht H, et al. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol. 2014;20:11182–98.CrossRefGoogle Scholar
  14. 14.
    Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer. 2009;8:109–17.CrossRefGoogle Scholar
  15. 15.
    Austin MA, Kuo E, Van Den Eeden SK, et al. Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study. Cancer Epidemiol Biomark Prev. 2013;22:1913–7.CrossRefGoogle Scholar
  16. 16.
    Jacobs EJ, Chanock SJ, Fuchs CS, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer. 2010;127:1421–8.CrossRefGoogle Scholar
  17. 17.
    Hassan MM, Bondy ML, Wolff RA, et al. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol. 2007;102:2696–707.CrossRefGoogle Scholar
  18. 18.
    Hruban RH, Petersen GM, Goggins M, et al. Familial pancreatic cancer. Ann Oncol. 1999;10(Suppl 4):69–73.CrossRefGoogle Scholar
  19. 19.
    Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis. 1985;38:289–93.CrossRefGoogle Scholar
  20. 20.
    Porta M, Fabregat X, Malats N, et al. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. Clin Transl Oncol. 2005;7:189–97.CrossRefGoogle Scholar
  21. 21.
    Zator Z, Whitcomb DC. Insights into the genetic risk factors for the development of pancreatic disease. Ther Adv Gastroenterol. 2017;10:323–36.CrossRefGoogle Scholar
  22. 22.
    Brune KA, Lau B, Palmisano E, et al. Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst. 2010;102:119–26.CrossRefGoogle Scholar
  23. 23.
    Matsubayashi H, Maeda A, Kanemoto H, et al. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Pancreas. 2011;40:974–8.CrossRefGoogle Scholar
  24. 24.
    Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004;64:2634–8.CrossRefGoogle Scholar
  25. 25.
    Molina-Montes E, Gomez-Rubio P, Márquez M, et al. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives. Int J Epidemiol. 2018;47:473–83.CrossRefGoogle Scholar
  26. 26.
    Lu C, Xu C-F, Wan X-Y, et al. Screening for pancreatic cancer in familial high-risk individuals: a systematic review. World J Gastroenterol. 2015;21:8678–86.CrossRefGoogle Scholar
  27. 27.
    Paiella S, Salvia R, De Pastena M, et al. Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: a systematic review and proportion meta-analysis of screening results. Pancreatology. 2018;18:420–8.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2019

Authors and Affiliations

  • Divyanshoo R. Kohli
    • 1
    • 5
  • Ken Robert Smith
    • 2
    • 3
    • 4
  • Jathine Wong
    • 2
    • 3
    • 4
  • Zhe Yu
    • 2
    • 3
    • 4
  • Kenneth Boucher
    • 2
    • 3
    • 4
  • Douglas O. Faigel
    • 1
  • Rahul Pannala
    • 1
  • Randall W. Burt
    • 2
    • 3
    • 4
  • Karen Curtin
    • 2
    • 3
    • 4
  • N. Jewel Samadder
    • 1
    Email author
  1. 1.Division of Gastroenterology and HepatologyMayo ClinicScottsdaleUSA
  2. 2.Department of Medicine (Gastroenterology), Huntsman Cancer InstituteUniversity of UtahSalt Lake CityUSA
  3. 3.Department of Oncological Sciences, Huntsman Cancer InstituteUniversity of UtahSalt Lake CityUSA
  4. 4.Department of Medicine (Genetic Epidemiology), Huntsman Cancer InstituteUniversity of UtahSalt Lake CityUSA
  5. 5.Division of Gastroenterology and HepatologyKansas City Veterans Affairs Medical CenterKansas CityUSA

Personalised recommendations